Keywordsβ-oxidation; carnitine/acylcarnitine translocase; citrate carrier; fatty acid synthesis; hormonal regulation; nutritional regulation; TSPO; tetrapyrrole; eukaryotes; prokaryotes; TSPO ligand binding; TSPO binding site structures; cell function; stress; homeostasis; life expectancy; translocator protein; methotrexate; TSPO-ligand; bio-conjugate; glioma; oxaliplatin; antitumor drugs; platinum(IV); translocator protein 18 kDa; TSPO; colorectal cancer; translocator protein; neurosteroidogenesis; PIGA ligands; cellular proliferation; oxidative metabolism; astrocytes; translocator protein; TSPO; Tricarbonyltechnetium-99m; 99mTc(CO)3; TSPO-rich tumors; SPECT; gonocytes; spermatogonia; translocator protein 18 kDa (TSPO); differentiation; human testis; germ cells; seminoma; mitochondria; translocator protein (TSPO); cholesterol recognition/interaction amino acid consensus (CRAC); permeability transition; modulation of nuclear gene expression; mitochondrial 18 kDa translocator protein (TSPO); TSPO ligand; PK 11195; 2-Cl-MGV-1; retrograde mitochondrial-nuclear signaling pathway; microscopy; mitochondria; cell nucleus; translocator protein (TSPO); neuroinflammation; steroidogenesis; subcellular targeting
